Epithelial to Mesenchymal Transition Relevant Subtypes with Distinct Prognosis and Responses to Chemo- or Immunotherapies in Osteosarcoma

Figure 8

Association of genes in EMT score with osteosarcoma prognosis in the TARGET cohort. (a)–(r) Kaplan-Meier survival analyses for high and low expression subgroups of (a) EEF1B2, (b) EIF4A1, (c) RPL10, (d) RPL11, (e) RPL12, (f) RPL13A, (g) RPL21, (h) RPL34, (i) RPL35A, (j) RPL36, (k) RPL37A, (l) RPS8, (m) RPS9, (n) RPS12, (o) RPS23, (p) RPS24, (q) RPS27A, and (r) RPS28 in the TARGET cohort.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)

(o)

(p)

(q)

(r)